No abstract available
MeSH terms
-
Alemtuzumab
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Neoplasm / therapeutic use*
-
Antineoplastic Agents / therapeutic use
-
Cryptococcosis / complications*
-
Cryptococcosis / immunology
-
Dermatomycoses / complications*
-
Dermatomycoses / immunology
-
Facial Dermatoses / complications*
-
Facial Dermatoses / immunology
-
Fatal Outcome
-
Humans
-
Immunocompromised Host
-
Immunosuppressive Agents / therapeutic use*
-
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
-
Leukemia, Lymphocytic, Chronic, B-Cell / microbiology
-
Male
-
Middle Aged
-
Sepsis / immunology
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Neoplasm
-
Antineoplastic Agents
-
Immunosuppressive Agents
-
Alemtuzumab